The arterial switch operation (ASO) is the gold standard operative correction of neonates with transposition of the great arteries and intact ventricular septum, with excellent operative survival. The associations between patient and surgeon characteristics and outcomes are well understood, but the associations between variation in preoperative care and outcomes are less well studied.
T ransposition of the great arteries (TGA) is the second most common form of cyanotic congenital heart disease. The arterial switch operation (ASO), first described by Jatene and colleagues 1 in 1976, has replaced atrial switch operations as the operation of choice in North American and European countries. Average operative mortality is ≈5% in the United States and Europe. 2, 3 Previous studies have identified patientlevel factors (low birth weight [4] [5] [6] [7] and variations in coronary anatomy [8] [9] [10] [11] [12] [13] ) and both hospital and surgeon experience 14 as factors that are associated with operative mortality. The associations between preoperative care (specifically the timing of ASO and use of other adjuvant therapies) and perioperative outcomes have not received the same attention in the current era.
Neonates with TGA inevitably experience hypoxemia. In some patients, the degree of hypoxemia is tolerable, but in others, insufficient atrium-level mixing, pulmonary parenchymal disease, or other issues can lead to shock and end-organ dysfunction. Adjuvant therapies, specifically the Rashkind balloon atrial septostomy (BAS), prostaglandin infusion, mechanical ventilation, and inotropic agents, have the potential to improve systemic arterial oxygen saturation and tissue oxygen delivery, but operative correction remains the ultimate treatment for hypoxia. Adjuvant therapies improve oxygen saturation in many cases. Availability of these therapies has created a more flexible window in which ASO can be performed. At the same time, each of these adjuvant therapies incurs not only economic cost but also a risk of complications. To the best of our knowledge, the associations between interhospital variation in preoperative care and perioperative outcome have not been thoroughly evaluated.
The use of adjuvant therapies and the timing of surgery are determined by both individual patient condition and hospital habitual practice. Disentangling these factors requires data from both a large number of patients and a number of hospitals with a range of practice patterns. To address this, we performed a multicenter retrospective cohort study using data from the PHIS database (Pediatric Health Information Systems), evaluating the association between preoperative care (timing of ASO and preoperative BAS, prostaglandin infusion, and mechanical ventilation) and perioperative outcomes (mortality, cost, and length of stay [LOS] ).
METHODS

Data Source
The PHIS database is an administrative database that contains data from inpatient, emergency department, ambulatory surgery, and observation encounters from 47 not-for-profit, tertiary care pediatric hospitals in the United States that are affiliated with the Children's Hospital Association (Overland Park, KS). Data quality and reliability are ensured through a joint effort between the Children's Hospital Association and participating hospitals. The data warehouse function for the PHIS database is managed by Truven Health Analytics (Ann Arbor, MI). Participating hospitals provide discharge/encounter data, including demographics, diagnoses, and procedures. Data are deidentified at the time of data submission and are subjected to a number of reliability and validity checks. A datause agreement was signed between study investigators and the Children's Hospital Association. The Institutional Review Board of The Children's Hospital of Philadelphia has previously determined that all studies using data from PHIS do not represent human subjects research in accordance with the Common Rule (45 CFR 46.102[f] ) and are exempt from Institutional Review Board review. The data, analytical methods, and study materials will not be made available to other researchers for purposes of reproducing the results or replicating the procedure because this would be a violation of our data-use agreement.
Study Population
Patients were identified with the use of International Classification of Diseases (ICD), Ninth Revision (ICD-9), codes. We included neonates (<30 days of age at admission) with a diagnosis of TGA who underwent an ASO (ICD, Tenth Revision [ICD-10], code 35.84) during the incident hospitalization with date of birth between January 1, 2010, and September 13, 2015. These dates were chosen to create a birth cohort with
Clinical Perspective
What Is New?
• There is significant variation in the care of neonates with transposition of the great arteries before arterial switch operation (ASO) beyond what could be explained by variability in case mix.
• Some of these differences in practice were associated with differences in clinical outcome. • At the individual subject level, receipt of balloon atrial septostomy was associated with lower mortality, length of stay, and cost.
• ASO in older neonates was associated with increased mortality, length of stay, and cost.
• Receipt of ASO at hospitals that habitually performed ASO later in life was also associated with increased risk of mortality.
What Are the Clinical Implications?
• Perioperative care should continue to be individualized on the basis of patient anatomy and physiology, although the potential risks of delaying ASO should be carefully considered, as should the potential benefit of septostomy.
• At the hospital level, these findings should be considered in organizing preoperative care of infants with transposition of the great arteries, prioritizing efficient evaluation and treatment of patients before ASO.
• Specifically, obstacles to timely ASO should be identified and efforts made to overcome them. ORIGINAL RESEARCH ARTICLE consistent data before the adoption of ICD-10 codes. Patients who underwent Rastelli-type operations or atrial switch operations were explicitly excluded. ICD-9 codes for procedures were used for cohort identification because they were more sensitive than diagnosis codes, as described previously. [15] [16] [17] [18] Cases from hospitals that did not contribute data to PHIS in at least two-thirds of the study years were excluded, as described previously. [15] [16] [17] [18] Preoperative extracorporeal membrane oxygenation (ECMO) was exceedingly rare. Cases in which it was used were excluded because they were not representative of either typical preoperative practice. Patients in whom ASO was performed at age >30 days represented <1% of cases. They were excluded because the focus of the study was on factors associated with outcomes in neonatal ASO.
Study Measures
Data were extracted from the PHIS database by direct query using ICD-9 codes for diagnoses and procedures and Clinical Transaction Codes for pharmaceutical products.
The primary exposure for this study was age at ASO. Age at ASO was calculated directly. Secondary exposures were BAS, prostaglandin infusion, mechanical ventilation, and inotrope infusions. Exposure to the last 3 was defined as receipt of the service >one-half day of service immediately before the operation, >3 total days of the preoperative period, or the 2 days immediately before the operation. This definition was chosen to exclude cases in which therapies were used transiently during initial stabilization and evaluation and those in which changes were made on the day of the operation. Information about these practices was collected for each patient. Patterns of resource use for each hospital were also studied as exposures, specifically the median age at ASO and the proportion of cases receiving BAS, prostaglandin infusion, mechanical ventilation, and inotrope infusions.
Three primary outcomes were identified before analysis: death before hospital discharge, LOS, and total cost. The sensitivity of identifying other postoperative complications was potentially limited, so they were not measured. Patientlevel covariates included subject age, sex, race (white, black, Asian, other, or missing), insurance payer (private, Medicaid, other governmental insurance, or other), presence of genetic syndrome, presence of noncardiac congenital anomalies, and history of prematurity. Gestational age of subjects was subdivided into 26 to 30, 31 to 34, 35 to 37, and ≥37 weeks for descriptive purposes but dichotomized (either >37 or ≤37 weeks) for subsequent analyses. Data about noncardiac medical conditions (divided by system, as has been previously described 19 ) were collected, as was the incidence of necrotizing enterocolitis (NEC) and sepsis. However, it is not possible in this database to determine which of these codes were present preoperatively and which occurred postoperatively. Including them as covariates in subsequent analyses would introduce risk of obscuring preoperative risk; thus, they were not included in our primary analyses. Sensitivity analyses were performed to evaluate the maximal degree to which excluding these covariates influenced the study results.
Measurable hospital-level covariates included hospital annual cardiac (cardiothoracic) surgical volume and ASOspecific operative volume. Hospital annual cardiothoracic surgical volumes were calculated for the study period, as described previously. 15 There was strong correlation between annual cardiothoracic surgical volume and number of ASOs performed (P<0.001, r 2 =0.85), but because mean annual total cardiothoracic surgical volume is more stable and reflective of programmatic size than ASO-specific volume, it was used for all subsequent analyses.
As described previously, 16, 17, 20, 21 several steps were taken to obtain cost data comparable between hospitals and across the entire study period. PHIS receives billing data directly from hospitals and converts these charges to costs using hospitaland department-specific ratios of costs to charges. Costs are also adjusted for regional wage-price indexes to provide costs comparable between hospitals across the country. Total costs for an entire hospitalization/encounter can be retrieved within the confines of our data-use agreement, but more detailed cost reports (ie, department-level or itemized costs) are not released. We further adjusted cost data to account for inflation using the Consumer Price Index for medical care, as compiled by the US Bureau of Labor Statistics (http://data.bls.gov/ cgi-bin/dsrv). All costs are expressed as year 2015 US dollars.
Statistical Analysis
The characteristics of the patients in the study population were described by calculating standard descriptive statistics. Continuous variables were expressed as mean±SD or median (interquartile range [IQR] and range) as appropriate. The proportion of cases with adverse outcomes is reported, along with the 95% CI.
A priority in the design of an observational study is to minimize bias and confounding. As described above, we restricted the study population to neonates undergoing ASO, further restricting cases that deviated from current conventional practice (late ASO or preoperative ECMO). We then sought to adjust for measurable confounders (eg, genetic syndrome or prematurity). There are also potential confounding variables that were poorly characterized in the database (NEC and sepsis). Because of the uncertainty in their definition, these were excluded from our initial analysis. Finally, there are aspects of patient anatomy and physiology (size of atrial communication or oxygen saturation) that are not measured in the database and cannot be included in our analysis. However, with a relatively large number of patients per hospital, it is unlikely that these characteristics would be distributed unevenly between centers.
To adjust for measurable confounders (patient and hospital characteristics), multivariable mixed-effects models using generalized linear models were used. A binomial frequency distribution (with logit link) was used for models of mortality, and a gamma distribution (with log link) was used for the models of cost and LOS. Cost and LOS are uniformly positive continuous outcomes with significant skew. There is not a single standard frequency distribution for these outcomes, but data from simulation studies support the use of the gamma distribution, 22 and it has been used previously with good model fit to study congenital heart disease. 16, 17, 21 For each model, fixed effects were covariates, as described below. A random intercept was added to account for covariance within individual hospitals. To avoid bias, no bivariable screening or model refinement was performed. 23 Conditional standardization was used to estimate outcomes for a standard-risk patient, as well as the 95% CIs.
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Analyses of the outcomes were performed in 2 steps. First, the association between patient-level factors and use of adjuvant therapies for individual infants was assessed. Outcomes were as described above. Covariates included the primary exposures described, prematurity, and identified genetic syndrome.
Second, we sought to study the association between hospital characteristics independently of patient characteristics and other adjuvant therapies by adding prespecified hospital characteristics to the models on the basis of patient-level factors and adjuvant therapies calculated in the previous step. The proportion of patients undergoing ASO who received BAS, ventilator support, or prostaglandin infusion; the mean age at ASO for each hospital; and the annual hospital volume of cardiothoracic surgical cases were included in these models. We hypothesized that at the hospital level, delayed ASO would be associated with higher use of adjuvant therapies and with worse outcomes (higher mortality, higher cost, and longer LOS).
On the basis of reported in-hospital mortality after ASO (≈5%), 2, 3 we expected that the number of in-hospital deaths would be insufficient for a multivariable analysis including all relevant covariates. 24 Instead, a set of exploratory analyses was performed, separately adding each of the hospital characteristics to the previously calculated patient characteristicsadjusted model for in-hospital mortality. In addition, before analysis, it was not clear that the association between age at ASO and death would be linear and monotonic. Therefore, a second set of analyses was performed evaluating the association between the risk of death and 1 of 3 age criteria: age at ASO <25th percentile, age at ASO >50th percentile, and age at ASO divided into 3 strata (<25th, 25th-50th, and >50th percentile). Because of the low event rate, analysis using splines or other methodologies was not feasible.
Several prespecified secondary analyses were performed. First, a model was developed using postoperative LOS (rather than total LOS) as an outcome to determine whether associations seen in models of total LOS were the result of preoperative or postoperative care. Analysis was performed for total LOS, and cost models were repeated restricted to patients who survived to hospital discharge to measure the degree to which patients who died affected our estimates. Analyses of multivariable models for LOS and cost were calculated including patient characteristics with each of the hospital characteristics individually to evaluate for covariance between hospital characteristics resulting in bias (data not shown). Post hoc sensitivity analyses were performed to determine whether correlation between use of BAS and timing of ASO affected observed associations. Isolating either factor did not affect the observed associations (data not shown).
Two post hoc analyses were performed. Because of clinical interest, the effect of including subjects with preoperative ECMO on risk of mortality, LOS, and cost was assessed. Because they reflect a distinct deviation from standard preoperative management, models for hospital characteristics were not recalculated with the addition of cases with preoperative ECMO. Second, to explore the extent to which the degree of prematurity was associated with outcome, additional post hoc models stratifying the population into term neonate and those with 35-to 37-week, 31-to 37-week, and ≤30-week gestations were calculated. Further exploration was not possible because of small numbers of subjects born very prematurely. Sensitivity analyses adding NEC and sepsis to models of patient characteristics were performed to evaluate the maximum degree that omitting them had on associations demonstrated in the primary model.
Missing data were generally infrequent (<1% for most variables). However, data for race were missing for a significant number of patients. To mitigate potential bias, a separate categorical variable for missing race was generated. Otherwise, cases with missing data were excluded by case restriction, and no imputation was applied because the benefit of addressing these rare instances was minimal. The primary analyses were prespecified, and other analyses should be considered exploratory. No formal adjustment for multiple comparisons was made.
All data analysis was performed with Stata MP 13 (StataCorp, College Station, TX). The threshold for statistical significance was P<0.05.
RESULTS
Patient Characteristics
Over the study period, 2159 patients at 40 hospitals met the inclusion criteria ( Figure 1 ). Of these patients, 63% were white and 68% were male, with 8% born prematurely ( Table 1 ). In terms of preoperative care, 49% underwent BAS, 60% received prostaglandin infusion, 37% underwent mechanical ventilation, and 1% received inotropes. Median age at ASO was 6 days (IQR, 4-9 days).
In-hospital mortality was 2.8% (95% CI, 2.1-3.6; Table 2 
Hospital Characteristics
The median annual number of ASO performed at the hospitals in the study sample was 8 (IQR, 6-11). The median hospital annual cardiothoracic surgical volume 135-302) . The propensity to use adjuvant therapies varied significantly between hospitals in the study sample (Figure 2) . The median hospital percentage of cases receiving prostaglandin was 67% (IQR, 36%-78%), with a range that spanned 18% to 95%. Similarly broad ranges were also seen in the use of BAS (median, 48%; IQR, 41%-61%; range, 22%-80%; Figure 3 ), mechanical ventilation (median, 33%; IQR, 15%-49%; range, 0%-87%), and age at ASO (median, 6 days; IQR, 5-8 days; range, 3-14 days; Figure 4) . Inotropes were used infrequently and in a more consistent fashion between hospitals (median, 0; IQR, 0%-6%; range, 0%-16%).
Correlations between hospital characteristics were measured (Table I in the online-only Data Supplement). Larger annual hospital surgical volume was associated with earlier age at ASO (r 2 =0.12, P=0.03; Figure 5 ). Increasing hospital propensity for BAS was associated with later average age at ASO (r 2 =0.20, P=0.004). Although not statistically significant, there was a positive correlation between hospital propensity for prostaglandin and hospital propensity for mechanical ventilation use (r 2 =0.09, P=0.06). Other hospital characteristics were not significantly associated with each other.
Associations Between Patient Characteristics and Outcomes
A multivariable model was developed to evaluate patient factors associated with in-hospital mortality ( Table 3) . The standardized risk of mortality for a patient with no risk factors operated on at day of life 6 was 3.7% (95% CI, 2.3-5.8). Preoperative exposure to inotropes was associated with higher odds of death (odds ratio [OR], 4.79; 95% CI, 1.00-23.01; P=0.05), whereas BAS was associated with lower odds of mortality (OR, 0.32; 95% CI, 0.17-0.58; P<0.001). Both genetic condition (OR, 6.00; 95% CI, 2.30-15.64; P<0.001) and prematurity (OR, 2.84; 95% CI, 1.44-5.58; P=0.002) were associated with higher risk of in-hospital mortality. The use of other adjuvant therapies was not associated with hospital mortality, nor was age at ASO (P=0.38) when age was treated as a continuous variable. However, in prespecified analyses in which age at ASO was not treated as a continuous variable, significant associations between age at ASO and mortality were seen. Specifically, ASO This box-and-whiskers plot depicts the distribution of the propensity to use prostaglandin (PGE) infusion, balloon atrial septostomy (BAS), mechanical ventilation, and inotrope infusions at the hospitals in the study sample. The horizontal line marks the percentage of cases treated with the adjuvant therapy at the median hospital. Upper and lower limits of the box depict the use rate at the 25th and 75th percentile hospitals. Whiskers are drawn to the adjacent value under the limit of 1.5 times the interquartile range. Values outside this limit are marked with filled circles.
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performed at an age older than median (6 days) was associated with higher risk of mortality (OR, 1.90; 95% CI, 1.11-3.26; P=0.02). Performing the arterial switch early (<25th percentile at 4 days) was not associated with a significant difference in risk (P=0.62). A model evaluating a nonlinear association between age at ASO and death did not demonstrate a significant difference for age <4 days versus 4 to 6 days (P=0.25), but ASO at >6 days was associated with higher risk than ASO at 4 to 6 days (OR, 1,88; 95% CI, 1.00-3.50; P=0.048). Analogous models for total hospital LOS and hospital cost were calculated (Table 3) . Standardized LOS was 23 days (95% CI, [21] [22] [23] [24] [25] , and standardized cost of hospitalization was 2015 US $147 127 (95% CI, 133 530-162 108). Both prematurity and presence of a genetic syndrome were associated with higher total LOS and hospital cost, as was increasing age at ASO. In terms of other preoperative factors, BAS was associated with a lower total LOS and cost, whereas preoperative mechanical ventilation was associated with higher total LOS and cost. Exposure to inotropes preoperatively was associated with significantly higher cost but not longer LOS. In a secondary analysis, a model for postoperative LOS was also calculated (Table II in the online-only Data Supplement); its point estimates and CIs were similar to those of the model for total LOS, with a standardized This bar graph depicts the proportion of cases in which a balloon atrial septostomy was performed at each hospital (y axis) in the study sample (x axis, sorted by ascending propensity for septostomy).
Figure 4. Hospital variation in age at arterial switch operation (ASO).
This bar graph depicts the median age at ASO (y axis) at each hospital in the study sample (x axis, sorted by ascending age at operation).
Circulation. [17] [18] [19] [20] . Sensitivity analyses including NEC and sepsis in primary models for mortality, LOS, and cost were performed with no effect on the associations described (data not shown).
Association Between Hospital Practice Patterns and Outcome
As expected, the number of in-hospital deaths was prohibitively low to include all hospital characteristics of interest in a single model. Therefore, a series of models was calculated with individual center characteristics added to the previously calculated model for mortality (Tables III to VII in A multivariable model was calculated to study the association between hospital practices and total LOS adjusted for patient characteristics (Table 4) . Increasing hospital average age at ASO was associated with longer LOS (P=0.004). The point estimate for increasing cardiothoracic surgical volume suggested a shorter LOS (ratio, 0.96; 95% CI, 0.92-1.00), but this was not statistically significant (P=0.05). In the analogous model for hospital cost (Table 4) , increasing median center age at ASO was associated with increased cost (P<0.001) independently of hospital annual cardiothoracic surgical volume. The point estimate for the associations between the propensity of each hospital to use prostaglandin (ratio, 1.32; 95% CI; 0.97-1.81; P=0.08) and cost was suggestive of a significant association between increasing use of prostaglandin and higher cost, but the association was not statistically significant. Similarly, the point estimate for the association between hospital cardiothoracic surgical volume (ratio, 0.96; 95% CI, 0.91-1.01; P=0.10) and cost suggested an association between higher surgical volume and lower cost, but the association was not statistically significant. Other preidentified center-level covariates were not associated with higher cost.
A prespecified secondary analysis of postoperative LOS demonstrated associations similar to the model for total LOS (Table VIII in This scatterplot depicts the association between hospital surgical volume and the median age at arterial switch at each hospital in the study sample (blue circles) with interquartile ranges depicted (brackets). Although there is a significant correlation between increasing size and decreasing age at arterial switch operation (solid red line), there is still broad variation in the distribution (r 2 =0.15). 
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tal cardiothoracic surgical volume and postoperative LOS still suggested that increasing volume was associated with shorter postoperative LOS (ratio, 0.95), but the association was no longer statistically significant (P=0.08). Sensitivity analyses restricting analyses of cost and total LOS to patients who survived to hospital discharge were performed. There were no changes in the estimates or significance of associations observed in the previous 2 models (data not shown).
Post Hoc Analyses
Two post hoc analyses were performed. First, patients with preprocedural ECMO were included, and the associations between ECMO and outcomes were evaluated. Preoperative ECMO was associated with higher risk of in-hospital mortality (OR, 6.03; 95% CI, 1.87-19.41; P=0.03) and higher cost (ratio, 1.58; 95% CI, 1.33-1.89; P<0.001). No significant association was seen with LOS (P=0.35). Associations between other individual-level covariates and mortality, LOS, and cost were unchanged (data not shown).
We also evaluated whether the observed associations between prematurity on outcome were proportional to the degree of prematurity. In the study population, 91% of patients were born at term, 5% at 35 to 37 weeks' gestation, 3% at 31 to 35 weeks' gestation, and 0.6% at ≤30 weeks' gestation. Relative to term gestation, gestational age ≤30 weeks was associated with higher odds of mortality (OR, 21.08; 95% CI, 3.21-138.25; P=0.001). The point estimates for the odds of mortality in gestational age 31 to 35 weeks (OR, 2.86) and 35 to 37 weeks (OR, 2.26) were consistent with higher risk, but they were not statistically significant (P=0.06; Table  IX in the online-only Data Supplement).
DISCUSSION
This retrospective multicenter cohort study sought to evaluate the association between perioperative care and outcomes after ASO. The ASO has become the dominant operation to provide anatomical and physiological correction of TGA. Contemporary series demonstrate excellent operative success and operative mortality. 2, 3, 25, 26 Previous studies have demonstrated an association between patient characteristics (birth weight <2.5 kg [5] [6] [7] 27 and variations in coronary artery origins [8] [9] [10] [11] 13 ) and operative mortality. Increasing center experience and surgeon experience also have been shown to be associated with lower risk of operative mortality.
14 However, less attention has been paid to the associations between (potentially modifiable) preoperative care and outcomes. We sought to evaluate these in a large multicenter administrative database.
In the present study, there was significant variation in practice, with large differences in the use of BAS, prostaglandin infusion, and mechanical ventilation before ASO and in the timing of eventual ASO. This was in sharp contrast to the small and relatively consistent proportion of patients who received inotropes, suggesting more consensus on the use of this therapy. The presence of variation in the use of the other practices is consistent with uncertainty about the optimal preoperative care for neonates awaiting ASO and the potential to improve outcomes by identifying potentially influential factors. Across medicine, efforts to reduce practice variation have improved outcomes and increased value in care. [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] The observed magnitude of this variation could not be explained by the case mix of each hospital. There is sufficient variation across hospitals in the sample to allow the evaluation of associations between hospital practice and outcomes.
The timing of the ASO has been of interest since the introduction of the operation. Seminal research from the 
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Congenital Heart Surgeons Society provided evidence that earlier ASO was associated with a lower risk of early mortality. 39 However, in an earlier era, those undergoing ASO included older patients with potentially different risk factors for adverse outcome. Contemporary series, in comparison, demonstrate that ASO is uniformly performed relatively early in neonatal life. 26, 27, 40 Conventional wisdom continues to support the notion that delaying ASO allows increased stability, allowing transition from fetal to neonatal circulation, maturation of the kidneys and liver, and evaluation/identification of other congenital anomalies. However, the optimal duration of this delay has not been clearly defined, and uncertainty about this is manifest in the tremendous variation in timing of ASO between hospitals seen in the present study. Single-center studies have also demonstrated that within their centers, ASO in the first few days of life was not associated with higher mortality and that delaying ASO incurred greater hospital cost. 40, 41 In addition, provocative case series of ASO performed in the first hours of life have demonstrated excellent technical success and mortality comparable to that in series with conventional timing. [42] [43] [44] In the present study, early ASO was not associated with higher mortality, whereas ASO at a later age was associated with higher mortality, LOS, and cost both at the level of the individual patient and in terms of hospital practice.
Care must be taken in the interpretation of the observed associations. First, because PHIS is an administrative database, it does not contain information on all of the potentially relevant clinical factors (eg, anatomic variants or degree of cyanosis). At this time, to the best of our knowledge, there are no evidence-based practice guidelines for thresholds of cyanosis or hypoxemia to guide whether BAS should be performed or the timing of ASO. The absence of these guidelines was part of the motivation to pursue this study and likely a contributor to the observed variability in practice. It is also unlikely that, over a relatively large number of patients per hospital, the degree of cyanosis is distributed unevenly. Individual patients might also have a noncardiac clinical condition (sepsis, NEC, or respiratory issues) that simultaneously would delay ASO and increase the likelihood of mortality, morbidity, and prolonged hospitalization. Some of the variation in timing of ASO might be the result of these factors. However, it is less plausible that these factors occur in sufficiently different frequency between hospitals to explain the tremendous variation in the median age at ASO at different centers (which is as low as 3 days at some centers and >10 days at other centers) and the observed associations between the hospital median age at ASO and outcome. This is evidence of systematic differences in timing of ASO between centers and an association between those differences and outcomes. There is a statistically significant correlation between smaller hospital surgical volume and later ASO. However, there is significant variability across the span of hospital sizes in terms of age at ASO, allowing separate evaluation of these factors. Second, the associations identified in an observational study do not imply causation. Further studies using experimental or quasiexperimental designs (such as a clinical trial) are necessary to accomplish this. A clinical trial would address this most directly. It also important to note that it is not possible to determine the mechanisms that underlie these associations. Despite these limitations, the observed associations point to potentially modifiable aspects of care that could improve outcomes and value delivered to patients with TGA. Further research is necessary to determine whether the benefit of early ASO is directly related to timing (as a result of reduced exposure to cyanosis and risk of iatrogenic events) or whether earlier ASO at individual hospitals is an indicator of hospital surgical program quality. Differentiating between these factors is an important step in determining how to translate these observations into practice.
The observed associations between BAS and lower mortality, cost, and LOS were unexpected. There has been controversy about the use of BAS, originating from a report that BAS was associated with a higher risk of stroke in this population. 45 Subsequent studies demonstrated that the risk of brain injury in this population was more strongly correlated with severity and duration of postnatal hypoxia than BAS, 46 but how to determine which patients receive BAS remains controversial. In the present study, some centers used BAS in <20% of cases, whereas in some hospitals, it was applied to >80% of cases (a >4-fold difference). As with timing of ASO, further research is necessary to determine the mechanism underlying the observed association (eg, an intrinsic benefit to improving mixing at the atrial level and effective pulmonary blood flow before cardiopulmonary bypass or improved saturations allowing reduced exposure to other adjuvants and associated risk of complications). It is also important to identify whether the superior outcomes associated with BAS are universal or whether they are restricted to a subset of patients.
At the hospital level, the use of prostaglandin infusion and mechanical ventilation was not significantly associated with perioperative outcomes. Preoperative use of mechanical ventilation was associated with shorter LOS and lower cost. Previous studies evaluating the association between these therapies and outcome have had equivocal results. 47 Widespread practice variation remains in the use of both prostaglandin infusion and mechanical ventilation. Along with the variation seen in ASO timing and BAS (which appear to have significant associations with outcome), there is value in identifying which patients would benefit from each of these therapies.
There are additional limitations to this study. First, it is not possible to determine if patients were prenatally diagnosed, the location of their delivery, and the proximity of the delivery hospital to the center at which ASO
was performed. Although data are equivocal in several studies, 5, [48] [49] [50] the interplay between these factors and the hemodynamic status of the patient and timing of ASO is an important target for future studies. We also did not include surgeon-specific data because this was beyond the scope of this study. Second, retrospective observational studies are limited to reporting the range of practices that exist. However, in this case, there is tremendous variability in the range of practices observed. Third, the study was restricted to short-term outcomes. The study period does not allow evaluation of the association between identified factors and the risk of reintervention and longer-term mortality. In addition, the study population was fixed, limiting the analysis of mortality because of its rarity and placing the study at risk of type II error. Last, PHIS contains data from US primary children's hospitals. This limits the generalizability of the study because the sample contains many large academic centers. However, the fact that there is significant variation in practice in this relatively homogeneous sample reaffirms that there is no consensus in the care of neonates before ASO.
CONCLUSIONS
Preoperative care of neonates awaiting ASO is highly variable between hospitals, beyond what can be explained by differences in case mix. There is evidence that aspects of this preoperative care (timing of ASO and use of BAS) may influence perioperative outcome. Despite the inherent limitations of an observational study, these findings suggest that further research into the optimal preoperative care of neonates with TGA with intact ventricular septum has the potential to improve outcomes in this population.
ARTICLE INFORMATION
